EKF Diagnostics Holdings plc
EKF.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | £0 | £0 | £0 | £0 |
| - Cash | £0 | £0 | £0 | £0 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £0 | £0 | £0 | £0 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | -4.6% | -21% | -18.6% | – |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | 42.8% | 45.3% | 36.1% | 48.1% |
| EBITDA | £0 | £0 | -£0 | £0 |
| % Margin | 22.2% | 14.6% | -3.3% | 33.5% |
| Net Income | £0 | £0 | -£0 | £0 |
| % Margin | 12.4% | 4.5% | -15.2% | 19.4% |
| EPS Diluted | 0.014 | 0.005 | -0.022 | 0.034 |
| % Growth | 165.4% | 123.5% | -164.2% | – |
| Operating Cash Flow | £0 | £0 | £0 | £0 |
| Capital Expenditures | -£0 | -£0 | -£0 | -£0 |
| Free Cash Flow | £0 | -£0 | £0 | £0 |